References
- Chandrasekharan NV, Simmons DL. The cyclooxygenases. Genome Biol 2004;5(9):1–7. doi:https://doi.org/10.1186/gb-2004-5-9-241.
- Yokoyama C, Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989;25(3):319–325.
- Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol 1998;38(1):97–120. doi:https://doi.org/10.1146/annurev.pharmtox.38.1.97.
- Wang LH, Hajibeigi A, Xu XM, Loose-Mitchell D, Wu KK. Characterization of the Promoter of Human Prostaglandin H Synthase-1 Gene. Biochem Biophys Res Commun 1993;190(2):406–411. doi:https://doi.org/10.1006/bbrc.1993.1062.
- Majed BH, Khalil RA. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev 2012;64(3):540–582. doi:https://doi.org/10.1124/pr.111.004770.
- Crescente M, Menke L, Chan MV, Armstrong PC, Warner TD. Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond). Br J Pharmacol 2019;176(8):988–999. doi:https://doi.org/10.1111/bph.14196.
- Gerrard JM, White JG, Rao GHR, Townsend D. Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol 1976;83(2):283–298.
- Otto JC, DeWitt DL, Smith WL. N-glycosylation of prostaglandin endoperoxide synthases-1 and −2 and their orientations in the endoplasmic reticulum. J Biol Chem 1993;268(24):18234–18242.
- Kirkby NS, Reed DM, Edin ML, Rauzi F, Mataragka S, Vojnovic I, Bishop‐Bailey D, Milne GL, Longhurst H, Zeldin DC. Inherited human group IVA cytosolic phospholipase A 2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation. Faseb J 2015;29(11):4568–4578. doi:https://doi.org/10.1096/fj.15-275065.
- Rivera J, Lozano ML, Navarro-Núñez L, Vicente García V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 2009;94(5):700–711. doi:https://doi.org/10.3324/haematol.2008.003178.
- Baigent C, Sudlow C, Collins R, Peto R. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71–86. doi:https://doi.org/10.1136/bmj.324.7329.71.
- Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2007;109(6):2285–2292. doi:https://doi.org/10.1182/blood-2006-01-010645.
- McFadyen JD, Schaff M, Peter K. Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol 2018;15(3):181–191. doi:https://doi.org/10.1038/nrcardio.2017.206.
- Xu XR, Yousef GM, Ni H. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood 2018;131(16):1777–1789. doi:https://doi.org/10.1182/blood-2017-05-743187.
- Guillem-Llobat P, Dovizio M, Bruno A, Ricciotti E, Cufino V, Sacco A, Grande R, Alberti S, Arena V, Cirillo M. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget 2016;7(22):32462–32477. doi:https://doi.org/10.18632/oncotarget.8655.
- Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995;83(3):483–492. doi:https://doi.org/10.1016/0092-8674(95)90126-4.
- Loftin CD, Tiano HF, Langenbach R. Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. Prostaglandins Other Lipid Mediat 2002;68–69:177–185. doi:https://doi.org/10.1016/S0090-6980(02)00028-X.
- Crescente M, Armstrong PC, Chan MV, Edin ML, Lih FB, Jiao J, Gaston-Massuet C, Cottrell GS, Kirkby NS, Mitchell JA, Zeldin DC, Herschman HR, Warner TD. Platelet cox-1 knockout mouse as a model of the effects of aspirin in the cardiovascular system. Hear Commun 2017;103(Suppl 5):A108 LP–A109.
- Mitchell JA, Shala F, Elghazouli Y, Warner TD, Gaston-Massuet C, Crescente M, Armstrong PC, Herschman HR, Kirkby NS. Cell-specific gene deletion reveals the antithrombotic function of COX1 and explains the vascular COX1/prostacyclin paradox. Circ. Res 2019;125(9):847–854. doi:https://doi.org/10.1161/CIRCRESAHA.119.314927.
- Lee CR, Bottone FG, Krahn JM, Li L, Mohrenweiser HW, Cook ME, Petrovich RM, Bell DA, Eling TE, Zeldin DC. Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1). Pharmacogenet. Genomics 2007;17(2):145–160. doi:https://doi.org/10.1097/01.fpc.0000236340.87540.e3.
- Li X-Q, Ma N, Li X-G, Wang B, Sun -S-S, Gao F, Mo D-P, Song L-G, Sun X, Liu L. Association of PON1, P2Y12 and COX1 with recurrent ischemic events in patients with extracranial or intracranial stenting. PLoS One 2016;11(2):e0148891. doi:https://doi.org/10.1371/journal.pone.0148891.
- Cai H, Cai B, Sun L, Zhang H, Zhou S, Cao L, Guo H, Sun W, Yan B, Davis SM. Association between PTGS1 polymorphisms and functional outcomes in Chinese patients with stroke during aspirin therapy: interaction with smoking. J. Neurol. Sci 2017;376:211–215. doi:https://doi.org/10.1016/j.jns.2017.03.014.
- Yi X, Zhou Q, Lin J, Chi L, Han Z. Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. J Atheroscler Thromb 2013;20(1):65–72. doi:https://doi.org/10.5551/jat.14092.
- Yi X, Cheng W, Lin J, Zhou Q, Wang C. Interaction between COX-1 and COX-2 variants associated with aspirin resistance in Chinese stroke patients. J Stroke Cerebrovasc Dis 2016;25(9):2136–2144. doi:https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.05.039.
- Weng Z, Li X, Li Y, Lin J, Peng F, Niu W. The association of four common polymorphisms from four candidate genes (COX-1, COX-2, ITGA2B, ITGA2) with aspirin insensitivity: a meta-analysis. PLoS One 2013;8(11):e78093. doi:https://doi.org/10.1371/journal.pone.0078093.
- Zhao J, Chen F, Lu L, Tang H, Yang R, Wang Y, Du Y. Effect of 106PEAR1 and 168PTGS1 genetic polymorphisms on recurrent ischemic stroke in Chinese patient. Medicine 2019;98(29):e16457. doi:https://doi.org/10.1097/MD.0000000000016457.
- Megy K, Downes K, Simeoni I, Bury L, Morales J, Mapeta R, Bellissimo DB, Bray PF, Goodeve AC, Gresele P. Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: communication from the SSC of the ISTH. J Thromb Haemost 2019;17(8):1253–1260. doi:https://doi.org/10.1111/jth.14479.
- Malmsten C, Hamberg M, Svensson J, Samuelsson B. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci 1975;72(4):1446–1450. doi:https://doi.org/10.1073/pnas.72.4.1446.
- Lagarde M, Byron PA, Vargaftig BB, Dechavanne M. Impairment of platelet Thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo‐oxygenase. Br J Haematol 1978;38(2):251–266. doi:https://doi.org/10.1111/j.1365-2141.1978.tb01041.x.
- Nyman D, Eriksson AW, Lehmann W, Blombäck M. Inherited defective platelet aggregation with arachidonate as the main expression of a defective metabolism of arachidonic acid. Thromb Res 1979;14(4–5):739–746. doi:https://doi.org/10.1016/0049-3848(79)90129-4.
- Pareti FI, Mannucci PM, D’Angelo A, Smith JB, Sautebin L, Galli G. Congenital deficiency of thromboxane and prostacyclin. Lancet 1980;315(8174):898–901. doi:https://doi.org/10.1016/S0140-6736(80)90837-5.
- Boda Z, Tamás E, Altorjay I, Pfliegler G, Rak K. Congenital deficiency of cyclo‐oxygenase in a woman with generalized atherosclerosis. Scand J Haematol 1981;27(2):65–69. doi:https://doi.org/10.1111/j.1600-0609.1981.tb00453.x.
- Horellou MH, Lecompte T, Lecrubier C, Fouque F, Chignard M, Conard J, Vargaftig BB, Dray F, Samama M. Familial and constitutional bleeding disorder due to platelet cyclo-oxygenase deficiency. Am J Hematol 1983;14(1):1–9. doi:https://doi.org/10.1002/ajh.2830140102.
- Nakanishi K, Ikeda K, Hato T, Kaneko H, Murakami A, Kuwashima K, Ikeda K, Fujita S, Kobayashi Y, Kaido H. Platelet cyclo-oxygenase deficiency in a Japanese. Scand J Haematol 1984;32(2):167–174. doi:https://doi.org/10.1111/j.1600-0609.1984.tb02173.x.
- Hiroaki E, Tanihiro Y, Shozo YAH. Enzymological and immunological studies on a clinical case of platelet cyclooxygenase abnormality. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1988;960:35–42.doi:https://doi.org/10.1016/0005-2760(88)90006-9
- Dubé JN, Drouin J, Aminian M, Plant MH, Laneuville O. Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. Br J Haematol 2001;113(4):878–885. doi:https://doi.org/10.1046/j.1365-2141.2001.02867.x.
- Matijevic-Aleksic N, Mcphedran P, Wu KK. Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency. Br J Haematol 1996;92(1):212–217. doi:https://doi.org/10.1046/j.1365-2141.1996.279813.x.
- Rolf N, Knoefler R, Bugert P, Gehrisch S, Siegert G, Kuhlisch E, Suttorp M. Clinical and laboratory phenotypes associated with the aspirin-like defect: A study in 17 unrelated families. Br. J. Haematol 2009;144(3):416–424. doi:https://doi.org/10.1111/j.1365-2141.2008.07468.x.
- Bastida JM, Benito R, Lozano ML, Marín-Quilez A, Janusz K, Martín-Izquierdo M, Hernández-Sánchez J, Palma-Barqueros V, Hernández-Rivas JM, Rivera J. Molecular diagnosis of inherited coagulation and bleeding disorders. Semin Thromb Hemost 2019;45(7):695–707. doi:https://doi.org/10.1055/s-0039-1687889.
- Yagmur E, Weiskirchen R, Schedel A, Bugert P. PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications. Thromb. Haemost 2013;110(11):1083–1085. doi:https://doi.org/10.1160/TH13-02-0110.
- Nance D, Campbell RA, Rowley JW, Downie JM, Jorde LB, Kahr WH, Mereby SA, Tolley ND, Zimmerman GA, Weyrich AS. Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants. J Thromb Haemost 2016;14(11):2230–2240. doi:https://doi.org/10.1111/jth.13500.
- Leinøe E, Zetterberg E, Kinalis S, Østrup O, Kampmann P, Norström E, Andersson N, Klintman J, Qvortrup K, Nielsen FC. Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, Scandinavia. Br J Haematol 2017;179(2):308–322. doi:https://doi.org/10.1111/bjh.14863.
- Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, Hernández-Sánchez JM, Riesco S, Bermejo N, González-García H. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica 2018;103(1):148–162. doi:https://doi.org/10.3324/haematol.2017.171132.
- Sivapalaratnam S, Melissa H, Lentaigne C, Chan M, Crescente M, Allan H, Wedderburn K, Hanif M, Turro E, Hart DP, Freson k, Downes K, Ouwehand W, Laffan M, Warner T . Congenital aspirin-like defect as a result of autosomal recessive variants in PTGS1. Blood Personal Commun 2018;132(Supplement 1):1156.
- Nakanishi K, Hato T, Imai A, Kaneko H, Murakami A, Kuwashima K, Ikeda K, Fujita S, Kobayashi Y, Kaido H,Kondo M, Hattori A. Platelet cyclo-oxygenase deficiency in a Japanese. Scand J Haematol. 1984 Feb;32(2):167-74. doi:https://doi.org/10.1111/j.1600-0609.1984.tb02173.x.